BRAF inhibitors for the treatment of metastatic melanoma: clinical trials and mechanisms of resistance (Q47572702)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	BRAF inhibitors for the treatment of metastatic melanoma: clinical trials and mechanisms of resistance	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22215904

retrieved

4 February 2018

reference URL

http://europepmc.org/abstract/MED/22215904

title

BRAF inhibitors for the treatment of metastatic melanoma: clinical trials and mechanisms of resistance (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22215904

retrieved

4 February 2018

reference URL

http://europepmc.org/abstract/MED/22215904

main subject

metastatic melanoma

1 reference

based on heuristic

inferred from title

author

Keith Flaherty

series ordinal

2

object named as

Keith T Flaherty

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22215904

retrieved

4 February 2018

author name string

Alexander Marzuka Alcalá

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22215904

retrieved

4 February 2018

reference URL

http://europepmc.org/abstract/MED/22215904

language of work or name

English

0 references

publication date

1 January 2012

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22215904

retrieved

4 February 2018

reference URL

http://europepmc.org/abstract/MED/22215904

published in

Clinical Cancer Research

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22215904

retrieved

4 February 2018

reference URL

http://europepmc.org/abstract/MED/22215904

volume

18

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22215904

retrieved

4 February 2018

reference URL

http://europepmc.org/abstract/MED/22215904

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22215904

retrieved

4 February 2018

reference URL

http://europepmc.org/abstract/MED/22215904

page(s)

33-39

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22215904

retrieved

4 February 2018

reference URL

http://europepmc.org/abstract/MED/22215904

cites work

Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation

1 reference

stated in

COCI

retrieved

24 May 2022

reference URL

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE09626

Mutations of the BRAF gene in human cancer

1 reference

stated in

COCI

retrieved

24 May 2022

reference URL

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE00766

Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K

1 reference

stated in

COCI

retrieved

24 May 2022

reference URL

https://opencitations.net/index/coci/api/v1/citations/10.1016/J.CCR.2010.11.023

Identifiers

DOI

10.1158/1078-0432.CCR-11-0997

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22215904

retrieved

4 February 2018

reference URL

http://europepmc.org/abstract/MED/22215904

PubMed publication ID

22215904

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22215904

retrieved

4 February 2018

reference URL

http://europepmc.org/abstract/MED/22215904

ResearchGate publication ID

51981497

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47572702&oldid=2160065868"